Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study

Total article views   Abstract views HTML views PDF downloads Totals
5,657 Dovepress* 4,496 630+ 1,437 5,126
PubMed Central* 0 531 286 531
Totals 4,496 1,161 1,723 5,657
*Since 16 April 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
27 0 0 0 13 14

View citations on PubMed Central and Google Scholar